Fukushima M - Search Results

1

Rapamycin enhances chemotherapy-induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells.

Shigematsu H, Yoshida K, Sanada Y, Osada S, Takahashi T, Wada Y, Konishi K, Okada M, Fukushima M. Shigematsu H, et al. Among authors: fukushima m. Int J Cancer. 2010 Jun 1;126(11):2716-25. doi: 10.1002/ijc.24990. Int J Cancer. 2010. PMID: 19856312

2

Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines.

Wada Y, Yoshida K, Suzuki T, Mizuiri H, Konishi K, Ukon K, Tanabe K, Sakata Y, Fukushima M. Wada Y, et al. Among authors: fukushima m. Int J Cancer. 2006 Aug 15;119(4):783-91. doi: 10.1002/ijc.21879. Int J Cancer. 2006. PMID: 16557585

3

Overexpression of the orotate phosphoribosyl-transferase gene enhances the effect of 5-fluorouracil on gastric cancer cell lines.

Taomoto J, Yoshida K, Wada Y, Tanabe K, Konishi K, Tahara H, Fukushima M. Taomoto J, et al. Among authors: fukushima m. Oncology. 2006;70(6):458-64. doi: 10.1159/000098873. Epub 2007 Jan 19. Oncology. 2006. PMID: 17237621

4

Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line.

Tsutani Y, Yoshida K, Sanada Y, Wada Y, Konishi K, Fukushima M, Okada M. Tsutani Y, et al. Among authors: fukushima m. Oncol Rep. 2008 Dec;20(6):1545-51. Oncol Rep. 2008. PMID: 19020740

5

The expression profiles of orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in gastric cancer and their clinical significance.

Oeda M, Yoshida K, Sanada Y, Wada Y, Suzuki T, Mizuiri H, Konishi K, Shigematsu H, Tanabe K, Fukushima M. Oeda M, et al. Among authors: fukushima m. Oncol Rep. 2006 Dec;16(6):1165-72. Oncol Rep. 2006. PMID: 17089033

6

Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cells.

Bijnsdorp IV, Peters GJ, Temmink OH, Fukushima M, Kruyt FA. Bijnsdorp IV, et al. Among authors: fukushima m. Int J Cancer. 2010 May 15;126(10):2457-68. doi: 10.1002/ijc.24943. Int J Cancer. 2010. PMID: 19816940

7

Overexpression of thymidylate synthase mediates desensitization for 5-fluorouracil of tumor cells.

Saga Y, Suzuki M, Mizukami H, Kohno T, Takei Y, Fukushima M, Ozawa K. Saga Y, et al. Among authors: fukushima m. Int J Cancer. 2003 Sep 1;106(3):324-6. doi: 10.1002/ijc.11221. Int J Cancer. 2003. PMID: 12845668

8

Aberrant methylation of DPYD promoter, DPYD expression, and cellular sensitivity to 5-fluorouracil in cancer cells.

Noguchi T, Tanimoto K, Shimokuni T, Ukon K, Tsujimoto H, Fukushima M, Noguchi T, Kawahara K, Hiyama K, Nishiyama M. Noguchi T, et al. Among authors: fukushima m. Clin Cancer Res. 2004 Oct 15;10(20):7100-7. doi: 10.1158/1078-0432.CCR-04-0337. Clin Cancer Res. 2004. PMID: 15501990

9

Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells.

Temmink OH, Hoebe EK, van der Born K, Ackland SP, Fukushima M, Peters GJ. Temmink OH, et al. Among authors: fukushima m. Br J Cancer. 2007 Jan 29;96(2):231-40. doi: 10.1038/sj.bjc.6603549. Br J Cancer. 2007. PMID: 17242697 Free PMC article.

10

Activator protein accelerates dihydropyrimidine dehydrogenase gene transcription in cancer cells.

Ukon K, Tanimoto K, Shimokuni T, Noguchi T, Hiyama K, Tsujimoto H, Fukushima M, Toge T, Nishiyama M. Ukon K, et al. Among authors: fukushima m. Cancer Res. 2005 Feb 1;65(3):1055-62. Cancer Res. 2005. PMID: 15705907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,011 results

Search Page

Filters